Diagnosis of venous thromboembolism during eltrombopag therapy for immune thrombocytopenia and successful replacement with romiplostim

被引：0
|
作者：
Amit, O. [1 ]
Kirgner, I [1 ]
Avivi, I [1 ]
机构：
[1] Tel Aviv Med Ctr & Sch Med, Hematol & Bone Marrow Unit, Tel Aviv, Israel
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2015年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO271-TUE
引用
收藏
页码：606 / 607
页数：2
相关论文
共 50 条
  • [1] Successful treatment of eltrombopag-resistant refractory immune thrombocytopenia with romiplostim
    Nakazato, Tomonori
    Ito, Chisako
    Mihara, Ai
    Aisa, Yoshinobu
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (02) : 291 - 293
  • [2] Successful treatment of eltrombopag-resistant refractory immune thrombocytopenia with romiplostim
    Tomonori Nakazato
    Chisako Ito
    Ai Mihara
    Yoshinobu Aisa
    [J]. International Journal of Hematology, 2013, 97 : 291 - 293
  • [3] ROMIPLOSTIM AND ELTROMBOPAG FOR IMMUNE THROMBOCYTOPENIA: METHODS FOR INDIRECT COMPARISON
    Cooper, Katy L.
    Fitzgerald, Patrick
    Dillingham, Kerry
    Helme, Kawitha
    Akehurst, Ron
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2012, 28 (03) : 249 - 258
  • [4] Use of eltrombopag after romiplostim in primary immune thrombocytopenia
    Ramon Gonzalez-Porras, Jose
    Eva Mingot-Castellano, Maria
    Andrade, Marcio M.
    Alonso, Rafael
    Caparros, Isabel
    Carmen Arratibel, Maria
    Fernandez-Fuertes, Fernando
    Jose Cortti, Maria
    Pascual, Cristina
    Sanchez-Gonzalez, Blanca
    Bernat, Silvia
    Angel Fuertes-Palacio, Miguel
    Andres Vazquez-Paganini, Juan
    Olivera, Pavel E.
    Teresa Alvarez-Roman, Maria
    Jarque, Isidro
    Cortes, Montserrat
    Martinez-Robles, Violeta
    Javier Diaz-Galvez, Francisco
    Calbacho, Maria
    Fernandez-Minano, Carmen
    Garcia-Frade, Javier
    Jose Gonzalez-Lopez, Tomas
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 (01) : 111 - 116
  • [5] The problem of immune thrombocytopenia refractory to both eltrombopag and romiplostim
    Al-Samkari, Hanny
    Schifferli, Alexandra
    Gonzalez-Lopez, Tomas J.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (04) : 1143 - 1145
  • [6] Romiplostim and Eltrombopag in Immune Thrombocytopenia as a Second-Line Treatment
    Bidika, Erjola
    Fayyaz, Hafsa
    Salib, Marina
    Memon, Areeba N.
    Gowda, Asavari S.
    Rallabhandi, Bhavana
    Cancarevic, Ivan
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (08)
  • [7] Thrombopoietin Level Predicts Response to Treatment with Eltrombopag and Romiplostim in Immune Thrombocytopenia
    Al-Samkari, Hanny
    Kuter, David J.
    [J]. BLOOD, 2018, 132
  • [8] Thrombopoietin level predicts response to treatment with eltrombopag and romiplostim in immune thrombocytopenia
    Al-Samkari, Hanny
    Kuter, David J.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (12) : 1501 - 1508
  • [9] Cost-minimization analysis of immune thrombocytopenia treatment with romiplostim and eltrombopag
    Marzal Alfaro, M. B.
    Marquinez Alonso, I.
    Escudero Vilaplana, V.
    Pernia Lopez, S.
    Sanjurjo Saez, M.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 975 - 976
  • [10] Role of thrombopoietin stimulating agents (Eltrombopag and Romiplostim) in immune thrombocytopenia secondary to SLE
    Toro-Velez, Esteban
    Nova-Escobar, Santiago
    Jaramillo-Arroyave, Daniel
    [J]. IATREIA, 2021, 34 (03) : 253 - 259
12345